Recon: Hims markets cheaper GLP-1 weight loss therapy in US; TrumpRx website to launch Thursday

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States